
Study: In low-income countries, few patients with highly resistant infections get the antibiotics they need
New research suggests only a fraction of multidrug-resistant bacterial infections in low- and middle-income countries (LMICs) are being treated with the right antibiotics. In a modeling study published this week in The Lancet Infectious Diseases, …